A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways

The H2.0-like homeobox transcription factor (HLX) regulates hematopoietic differentiation and is overexpressed in Acute Myeloid Leukemia (AML), but the mechanisms underlying these functions remain unclear. We demonstrate here that HLX overexpression leads to a myeloid differentiation block both in z...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 9; no. 1; pp. 3090 - 17
Main Authors Piragyte, Indre, Clapes, Thomas, Polyzou, Aikaterini, Klein Geltink, Ramon I., Lefkopoulos, Stylianos, Yin, Na, Cauchy, Pierre, Curtis, Jonathan D., Klaeylé, Lhéanna, Langa, Xavier, Beckmann, Cora C. A., Wlodarski, Marcin W., Müller, Patrick, Van Essen, Dominic, Rambold, Angelika, Kapp, Friedrich G., Mione, Marina, Buescher, Joerg M., Pearce, Erika L., Polyzos, Alexander, Trompouki, Eirini
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 06.08.2018
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The H2.0-like homeobox transcription factor (HLX) regulates hematopoietic differentiation and is overexpressed in Acute Myeloid Leukemia (AML), but the mechanisms underlying these functions remain unclear. We demonstrate here that HLX overexpression leads to a myeloid differentiation block both in zebrafish and human hematopoietic stem and progenitor cells (HSPCs). We show that HLX overexpression leads to downregulation of genes encoding electron transport chain (ETC) components and upregulation of PPARδ gene expression in zebrafish and human HSPCs. HLX overexpression also results in AMPK activation. Pharmacological modulation of PPARδ signaling relieves the HLX-induced myeloid differentiation block and rescues HSPC loss upon HLX knockdown but it has no effect on AML cell lines. In contrast, AMPK inhibition results in reduced viability of AML cell lines, but minimally affects myeloid progenitors. This newly described role of HLX in regulating the metabolic state of hematopoietic cells may have important therapeutic implications. HLX transcription factor regulates haematopoietic stem and progenitor cell (HSPC) differentiation and is overexpressed in acute myeloid leukemia. Here the authors show that HLX overexpression leads to myeloid differentiation block in zebrafish and human HSPCs by direct regulation of metabolic pathways.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-018-05311-4